Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

U.S. trade office reviewing India's Supreme Court drug ruling
Reuters
Wednesday, April 3, 2013 - 8:39am
tags:
Novartis, Glivec, patents, India
Isis Publishes Encouraging Data
Yahoo/Zacks
Wednesday, April 3, 2013 - 8:38am
tags:
Isis Pharmaceuticals, antisense
AstraZeneca's MedImmune unit acquires AlphaCore Pharma
Yahoo/Fly on the Wall
Wednesday, April 3, 2013 - 8:37am
tags:
AstraZeneca, M&A, MedImmune, AlphaCore Pharma
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tuesday, April 2, 2013 - 10:58am
tags:
Arena Pharmaceuticals, Zogenix, Delcath, Aveo Pharmaceutical, Vivus, Titan Pharmaceuticals, Bristol-Myers Squibb, Merck, Gilead, AbbVie, Amarin, Achillion, Sangamo BioSciences, Raptor Pharmaceuticals, Vertex Pharmaceuticals, NewLink Genetics, AstraZeneca, Rigel, Depomed, Biogen Idec, Sucampo, Dendreon, Valeant Pharmaceuticals, GSK, Aegerion
Zalicus Granted Key Formulation Patent for Z160
Yahoo
Tuesday, April 2, 2013 - 10:54am
tags:
Z160, Zalicus
Obagi Medical gets higher offer from Merz Pharma
Reuters
Tuesday, April 2, 2013 - 10:53am
tags:
M&A, Merz, Obagi Medical Products, Valeant Pharmaceuticals
3 Contenders With Novel, Non-Invasive Treatments For Cancer
Seeking Alpha
Tuesday, April 2, 2013 - 10:26am
tags:
AngioDynamics, cancer, OncoSec, Agenus, QS-21, NeoPulse, ImmunoPulse
Immunomedics settles Finra arbitration proceedings
The Fly on the Wall
Tuesday, April 2, 2013 - 10:23am
tags:
Finra, Immunomedics
Will AMR-001 Lead Neostem To The Promised Land?
Seeking Alpha
Tuesday, April 2, 2013 - 10:11am
tags:
AMR-001, NeoStem
Gilead's HCV Study to Continue
Yahoo/Zacks
Tuesday, April 2, 2013 - 10:10am
tags:
hepatitis C, Gilead, sofosbuvir, ledipasvir
US green light for Teva birth control pill
Pharma Times, UK
Tuesday, April 2, 2013 - 10:09am
tags:
Teva, FDA, birth control pill, Quartette
Many Docs & Researchers Know Little About The Sunshine Rule
Pharmalot
Tuesday, April 2, 2013 - 10:08am
tags:
physicians, Physician Payment Sunshine Act
Apricus Biosciences announces sale of non-core assets
Yahoo/Fly on the Wall
Tuesday, April 2, 2013 - 10:07am
tags:
Apricus Biosciences, NitroMist, Biocodex, Totect
SciClone Q4 Net Drops Steeply
Motley Fool
Tuesday, April 2, 2013 - 10:05am
tags:
earnings, SciClone Pharmaceuticals
Optimer Said to Draw Takeover Interest From Glaxo, Astellas
Bloomberg
Tuesday, April 2, 2013 - 10:04am
tags:
GSK, Astellas, M&A, Optimer Pharmaceuticals, AstraZeneca, Cubist Pharmaceuticals
Clavis Pharma May Close or Be Taken Over After Failed Drug Trial
Bloomberg
Tuesday, April 2, 2013 - 10:03am
tags:
Clavis Pharma, leukemia, elacytarabine
Ampio's Eye Drug Trial Design Won't Pass FDA Muster
TheStreet.com
Tuesday, April 2, 2013 - 9:56am
tags:
FDA, clinical trials, Ampio Pharmaceuticals, Optina, diabetic macular edema
Potential Lilly Investment Would Further Expand Indianapolis Insulin Manufacturing Operations
Yahoo
Tuesday, April 2, 2013 - 9:55am
tags:
Eli Lilly, drug manufacturing, insulin
AstraZeneca says Pulmicort Respules patent ruled invalid
Yahoo/Fly on the Wall
Tuesday, April 2, 2013 - 9:55am
tags:
Pulmicort, patents, AstraZeneca
Will Novartis decision impact U.S. drug prices?
Marketwatch
Tuesday, April 2, 2013 - 9:53am
tags:
drug pricing, generics, patents, Glivec, Novartis, India

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.